CIK 0001621227 · Non-accelerated filer<br>Smaller reporting company
Adaptimmune Therapeutics PLC
Sign in to watch- Ticker
- ADAPY
- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- United Kingdom
- Entity type
- operating
- Phone
- 44 1235 430000
- Business address
- 60 JUBILEE AVENUE, MILTON PARK, ABINGDON, OXFORDSHIRE, United Kingdom
- Former names
- Adaptimmune Ltd
- SC 13G/A Stake Amended Statement of Ownership
- 4 Open-market sale Chief Executive Officer sold 39,384 shares at an average $0.70 ($27,594)
- 4 Open-market sale Chief Medical Officer sold 20,563 shares at an average $0.69 ($14,106)
- 4 Open-market sale Chief Patient Supply Officer sold 22,795 shares at an average $0.70 ($15,889)
- 4 Open-market sale Chief Operating Officer sold 23,589 shares at an average $0.70 ($16,423)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale Chief Medical Officer sold 11,808 shares at an average $0.85 ($10,015)
- 4 Open-market sale Chief Operating Officer sold 9,229 shares at an average $0.85 ($7,813)
- 4 Open-market sale Chief Executive Officer sold 29,202 shares at an average $0.85 ($24,734)
- 4 Open-market sale Chief Patient Supply Officer sold 9,229 shares at an average $0.85 ($7,813)
- 8-K Event Regulation FD disclosure
- 8-K Event Other events
Page 7 of 41 · 808 filings